Christine Xu Bio

Christine has extensive experience in Hong Kong initial public offerings, pre-IPO investment, post-IPO equity financing, M&A transactions and post-IPO compliance work, with a focus on advising new economy issuers in the technology, healthcare and consumer sectors. Christine is highly regarded for her expertise in new economy listings in Hong Kong, including the listings of pre-revenue specialist technology companies under Chapter 18C, pre-revenue biotech companies under Chapter 18A, and issuers with weighted voting rights (WVR) and VIE structures, as well as in dual primary listings, secondary listings and spin-off listings.